학술논문

Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone with or Without Radiotherapy in Primary Mediastinal Large B-Cell Lymphoma: The Emerging Standard of Care.
Document Type
Article
Source
Oncologist; Feb2012, Vol. 17 Issue 2, p239-250, 12p, 4 Charts, 1 Graph
Subject
ANTINEOPLASTIC agents
THERAPEUTIC use of monoclonal antibodies
RADIOTHERAPY
B cell lymphoma
COMBINATION drug therapy
COMPARATIVE studies
DOXORUBICIN
FISHER exact test
HEALTH outcome assessment
PREDNISONE
SURVIVAL analysis (Biometry)
VINCRISTINE
TREATMENT effectiveness
CONTINUING education units
DISEASE remission
PROPORTIONAL hazards models
RETROSPECTIVE studies
CYCLOPHOSPHAMIDE
DATA analysis software
KAPLAN-Meier estimator
Language
ISSN
10837159
Abstract
Copyright of Oncologist is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)